Treatment Duration With Long-Acting Injectable Antipsychotics After In-hospital Initiation: A Retrospective Cohort Study.

@article{Rittmannsberger2017TreatmentDW,
  title={Treatment Duration With Long-Acting Injectable Antipsychotics After In-hospital Initiation: A Retrospective Cohort Study.},
  author={Hans Rittmannsberger and Jan Rosenleitner and Gertraud Malsiner-Walli and Regina Werl and Barbara Rittmannsberger and Kurosch Yazdi},
  journal={Journal of clinical psychopharmacology},
  year={2017},
  volume={37 2},
  pages={
          250-254
        }
}

• Hans Rittmannsberger, Jan Rosenleitner, +3 authors Kurosch Yazdi
• Published in Journal of clinical psychopharmacology 2017
• DOI:10.1097/JCP.0000000000000672

PURPOSE Long-acting injectable (LAI) antipsychotics are recommended especially for patients with multiple admissions and poor adherence. The empirical basis of this strategy is a matter of debate. METHODS In a retrospective cohort study extending over 6 years, all patients admitted for inpatient treatment with a diagnosis of psychotic disorders according to International Statistical Classification of Diseases and Related Health Problems, 10th Revision (F2) were screened for treatment episodes… CONTINUE READING

Save to Library

Create Alert

Cite

View on PubMed